Scoliosis Management Market

Scoliosis Management Market Outlook (2024 to 2034)

Worldwide revenue from the global scoliosis management market is estimated to reach US$ 3.05 billion in 2024. The market is analyzed to climb to a value of US$ 4.39 billion by the end of 2034, expanding at a CAGR of 3.7% over the next ten years.

Scoliosis is characterized by abnormal sideways curvature of the spine. While a slight curvature is normal, a more pronounced curve in the shape of an S or C is associated with scoliosis. Although the exact cause of scoliosis is not known, factors such as genetics, neuromuscular disorders, and congenital abnormalities of the spine are known to be risk factors.

While the disease affects both sexes equally, the progression of the curve in females is eight times faster than in males. Nevertheless, the patient must wear the device for 22 to 23 hours every day, which stiffens their body and causes skin irritation and rashes. In addition, it causes breathing difficulties and presses against the chest wall and abdomen, which may impair pulmonary and oxygen flow.

Key Market Growth Drivers

• The market for scoliosis management is being positively influenced by the increasing aging population globally because degenerative forms of the disorder become more common as people become older.
• Key market participants are heavily investing in R&D to increase the range of products they offer, which is projected to fuel market expansion.
• Important developments in the market include new product releases, agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. In an increasingly competitive and growing market, the scoliosis treatment industry is producing goods at a reasonable price.
• Rising prevalence of scoliosis, the high adoption rate of braces, and technological advancements such as tracking devices to monitor patients’ health are the primary factors contributing to the expansion of the scoliosis management market size. The increasing need for less invasive treatments is also expected to fuel the demand for scoliosis management solutions.
• Other factors that are projected to boost market growth over the forecast period include more people becoming aware of the need for braces and the availability of less expensive braces.
• Producers are putting more and more effort into creating products that are easier to use. The market for scoliosis management is expanding at a noteworthy pace as a result of several businesses investing heavily in R&D.

Report Attribute	Detail
Scoliosis Management Market Size (2024E)	US$ 3.05 Billion
Forecasted Market Value (2034F)	US$ 4.39 Billion
Global Market Growth Rate (2024 to 2034)	3.7% CAGR
Latin America Market Share (2024E)	8.3%
North America Market Share (2024E)	39.5%
Revenue from Online Sales (2024E)	US$ 1.22 Billion
Key Companies Profiled	DJO Global; TRULIFE; Wellinks, Inc.; Horton’s Orthotics & Prosthetics; Boston O&P; Bauerfeind AG; Spinal Technology Inc.; GE Healthcare; Zimmer Biomet; Medtronic; Exponent Inc.

Which Scoliosis Management Market Trends are Advantageous to Manufacturers?

“Government Initiatives and Funding for Scoliosis Research and Treatment Development”

Juvenile scoliosis is diagnosed between the ages of 5 and 9 years. Scoliosis tends to grow faster at this age, meaning that it is becoming progressive and does not go away on its own. Young people with scoliosis typically experience a right bend. Since scoliosis advances with age, patients receiving brace treatment have their spines strengthened and the condition's progressiveness is halted. A child's growth necessitates changing the braces every 12 to 18 months due to varying degrees of curvature, which is driving market growth.

• According to the American Association of Neurological Surgeons (AANS), scoliosis primarily manifests in people between the ages of 10 and 15, with equal incidence in both genders. The likelihood of females progressing to a curve magnitude that necessitates treatment is eight times higher.

High prevalence of the condition, developments in cutting-edge technologies, government support, and growing demand for non-invasive surgical therapies are contributing to scoliosis management market growth.

What Challenges are Faced by Providers of Scoliosis Management Solutions?

“High Cost of Therapy and Less Awareness about Scoliosis”

Insufficient awareness about scoliosis, its signs, and available treatments are limiting the growth of the market. There is a lack of awareness about the illness among a large number of people, including patients, caregivers, and even medical professionals, which could cause delays in the diagnosis and start of treatment.

Scoliosis sometimes goes undetected or is mistakenly diagnosed as a benign postural problem because it develops gradually and can first manifest as subtle symptoms such as uneven hips or shoulders. As a result, individuals might require quicker medical attention. Demand for scoliosis management is being restricted by a lack of skilled healthcare providers, unfavorable payment policies, and a lack of awareness about the condition and treatment options.

Country-wise Insights

There is a high demand for diagnosis and treatment options in North America due to the rising prevalence of scoliosis among the population, especially among teenagers.

• The American Association of Neurology estimates that between 6 and 9 million people in the United States have scoliosis or 2% to 3% of the population. Furthermore, it is estimated that 29,000 teenage patients in the country undergo scoliosis surgery each year. Scoliosis is responsible for 20% of all cases of spine deformities and 1.2% of annual hospital costs in the United States.

What are the Factors Boosting Demand for Scoliosis Management in the United States?

“Well-established Healthcare System and High Prevalence of Scoliosis”

Attribute	United States
Market Value (2024E)	US$ 979 Million
Growth Rate (2024 to 2034)	3% CAGR
Projected Value (2034F)	US$ 1.31 Billion

The United States is estimated to hold 81.2% of the scoliosis management market share in North America in 2024. The country’s well-established healthcare system is expected to drive significant revenue growth for the market.

• The American Association of Neurological Surgeons (AANS) states that approximately 600,000 patients see private facilities annually, over 30,000 teenagers wear braces, and approximately 38,000 patients have spinal fusion procedures performed in the United States.
• Alphatec Spine Inc., a California-based medical device company that designs, develops, manufactures, and markets spinal fusion technology products and solutions, introduced the Arsenal Deformity Adolescent Idiopathic Scoliosis (AIS) System in the United States.
• In May 2023, the United States Food and Drug Administration offered clearance for REFLECTTM Scoliosis Correction System, Globus Medical’s first humanitarian product. The goal of the REFLECTTM procedure is to treat young patients with progressive scoliosis while preserving their range of motion, preserving their stability, and allowing for future controlled growth.

How is the Market for Scoliosis Management Solutions Evolving in Brazil?

“Increased Adoption of Orthopedic Implants Essential to Scoliosis Management”

Attribute	Brazil
Market Value (2024E)	US$ 198 Million
Growth Rate (2024 to 2034)	3.6% CAGR
Projected Value (2034F)	US$ 282 Million

Brazil is estimated to account for 78.2% market share in Latin America in 2024. The increased incidence of scoliosis in Brazil is fueling the need for management strategies. The adoption of orthopedic implant adoption is gaining traction, which is fueling market expansion. These implants are essential to the management of scoliosis. The market is further stimulated by an increasing number of scoliosis surgeries.

Category-wise Insights

The thoracolumbosacral orthosis (TLSO) product segment is projected to expand at a steady rate over the projection period. Based on age group, the market is segmented into three segments: infantile, adolescent, and young adult. Adolescents are set to account for 72% of the global market share in 2024.

Why Does Thoracolumbosacral Orthosis (TLSO) Occupy a Significant Market Share?

“Role of TLSO Management in Protecting Lower Thoracic Spine”

Attribute	Thoracolumbosacral Orthosis
Segment Value (2024E)	US$ 2.48 Billion
Growth Rate (2024 to 2034)	3.8% CAGR
Projected Value (2034F)	US$ 3.6 Billion

The thoracolumbosacral orthosis (TLSO) sub-segment is expected to hold 81.3% market share in terms of value in 2024. The lower thoracic spine is suitably protected by a well-built TLSO. An intact rib cage reduces fracture displacement and offers relative stability in the upper thoracic spine.

It is hard to immobilize this section of the spine with straightforward orthoses. Despite frequent attempts, effective immobilization of the lumbar spine-particularly its lower segment and the lumbosacral junction-is challenging to accomplish through orthotic means. To attain optimal external immobilization for the lowest spine regions, it is necessary to use a hip spica or a rigid pelvic girdle.

What Advantages do Comprehensive e-Commerce Platforms Offer?

“e-Commerce Platforms Facilitating Informed Decision-making for Equipment Purchases”

Attribute	Online Sales
Segment Value (2024E)	US$ 1.22 Billion
Growth Rate (2024 to 2034)	3.8% CAGR
Projected Value (2034F)	US$ 1.77 Billion

The online channel is set to hold 40% of the market share in 2024. Pharmaceutical vendors provide patients and healthcare providers with a quick and easy way to find and buy the tools they require by integrating e-commerce platforms. This implies that patients can buy and receive their prescription medications from the convenience of their own homes in a business-to-consumer setting.

Comprehensive pharmaceutical e-commerce platforms, when used in a business-to-business setting, can enable suppliers to make educated drug purchases by comparing and contrasting all of the various, ever-changing factors involved in drug purchases, such as the prices and availability of various drugs at any given time.

Competitive Landscape

Key players in the scoliosis management market are investing in research & development to expand and enhance their product offerings. Mergers and acquisitions and collaborations with other organizations are examples of significant market developments. Producing affordable goods is essential for the scoliosis treatment industry to grow in an increasingly competitive and expanding market.

To improve their position in markets across the globe, a sizable portion of businesses involved in the global scoliosis management market are focusing their efforts on establishing alliances and partnerships with local distributors and retailers.

• NuVasive Inc. announced the launch of MAGEC X in the United Kingdom for the treatment of early-onset scoliosis.

Fact.MR provides detailed information about the price points of key providers of scoliosis management solutions positioned across the world, sales growth, production capacity, and speculative technological expansion, in this new market report.

Segmentation of Scoliosis Management Market Research

• By Indication :

  • Cervical Thoracic Lumbar
  • Thoracolumbosacral Orthosis
  • Lumbosacral Orthosis

• By Age Group :

  • Infantile Scoliosis
  • Juvenile Scoliosis
  • Adolescent Scoliosis

• By Distribution Channel :

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Sales

• By Region :

  • North America
  • Western Europe
  • Eastern Europe
  • Latin America
  • East Asia
  • South Asia & Pacific
  • Middle East & Africa